PMV Pharmaceuticals, Inc. (PMVP): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

52.54M
Year ended 2025-12-31
+4.8%
3-year compound annual growth
2020-12-31: 14.36M2021-12-31: 45.14M2022-12-31: 45.59M2023-12-31: 48.01M2024-12-31: 51.58M2025-12-31: 52.54M52.54M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3152.54M+1.9%2026-03-06, From 2025-01-01
2024-12-3151.58M+7.4%2026-03-06, From 2024-01-01
2023-12-3148.01M+5.3%2026-03-06, From 2023-01-01
2022-12-3145.59M+1.0%2025-03-03, From 2022-01-01
2021-12-3145.14Mn/c2024-02-29, From 2021-01-01
2020-12-3114.36Mn/a2023-03-01, From 2020-01-01